Eletriptan has 2 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Deferasirox, Paclitaxel. Patients taking Eletriptan should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Moderate
- 2
Moderate (2)
- Eletriptan + Deferasirox— Deferasirox may induce CYP3A4 resulting in decreased eletriptan concentration. Monitor for reduced effectiveness.
- Eletriptan + Paclitaxel— CYP3A4 substrate; caution should be exercised when administering paclitaxel concomitantly.